Teladoc Inc (TDOC)

$12.02

+1.4

(+13.18%)

Market is closed - opens 8 PM, 26 Nov 2024

Teladoc Inc Key Statistics

Market Capitalization
$1.5B
Revenue TTM
$2.6B
EBITDA
$66.2M
Earnings Per Share (EPS)
$-5.78
Profit Margin
-37.91%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-51.65%

Teladoc Inc share price movements

  • $11.14
    $12.38
    $12.02
    downward going graph

    7.32%

    Downside

    Day's Volatility :9.98%

    Upside

    2.87%

    downward going graph
  • $6.76
    $22.54
    $12.02
    downward going graph

    43.76%

    Downside

    52 Weeks Volatility :70.01%

    Upside

    46.67%

    downward going graph

Teladoc Inc Returns

PeriodTeladoc IncSector (Health Care)Index (Russel 2000)
3 Months
64.43%
-6.4%
0.0%
6 Months
5.81%
0.7%
0.0%
1 Year
-30.16%
10.9%
0.0%
3 Years
-89.03%
10.2%
-21.2%

Analyst Recommendation on Teladoc Inc

Hold
    31%Buy
    68%Hold
    0
    0%Sell
Based on 35 Wall street analysts offering stock ratings for Teladoc Inc(by analysts ranked 0 to 5 stars)
Based on 35 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
10
Hold
24
24
23
Sell
00
00
00

Analyst Forecast on Teladoc Inc

What analysts predicted

Downside of 11.26%

Current $12.02
Target $10.67

Insights on Teladoc Inc

  • Decreasing Revenue

    Revenue is down for the last 4 quarters, 660.52M → 640.50M (in $), with an average decrease of 1.0% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -837.67M → -33.27M (in $), with an average increase of 2417.3% per quarter

  • Vs DOCS

    In the last 1 year, Doximity, Inc. has given 98.5% return, outperforming this stock by 129.2%

  • Vs HQY

    In the last 3 years, Teladoc Inc has experienced a drawdown of -89.0%, however Healthequity Inc resisted the overall trend and outperformed by 68.7%

Teladoc Inc Financials in INR & Dollars

FY18Y/Y Change
Revenue
417.9M
↑ 79.14%
Net Income
-97.1M
↓ 9.08%
Net Profit Margin
-23.23%
↑ 22.54%
FY19Y/Y Change
Revenue
553.3M
↑ 32.4%
Net Income
-98.9M
↑ 1.83%
Net Profit Margin
-17.87%
↑ 5.36%
FY20Y/Y Change
Revenue
1.1B
↑ 97.71%
Net Income
-485.1M
↑ 390.71%
Net Profit Margin
-44.35%
↓ 26.48%
FY21Y/Y Change
Revenue
2.0B
↑ 85.81%
Net Income
-428.8M
↓ 11.61%
Net Profit Margin
-21.09%
↑ 23.26%
FY22Y/Y Change
Revenue
2.4B
↑ 18.41%
Net Income
-13.7B
↑ 3085.58%
Net Profit Margin
-567.53%
↓ 546.44%
FY23Y/Y Change
Revenue
2.6B
↑ 8.13%
Net Income
-220.4M
↓ 98.39%
Net Profit Margin
-8.47%
↑ 559.06%
Q2 FY23Q/Q Change
Revenue
652.4M
↑ 3.68%
Net Income
-65.2M
↓ 5.85%
Net Profit Margin
-9.99%
↑ 1.01%
Q3 FY23Q/Q Change
Revenue
660.2M
↑ 1.2%
Net Income
-57.1M
↓ 12.43%
Net Profit Margin
-8.64%
↑ 1.35%
Q4 FY23Q/Q Change
Revenue
660.5M
↑ 0.04%
Net Income
-28.9M
↓ 49.38%
Net Profit Margin
-4.37%
↑ 4.27%
Q1 FY24Q/Q Change
Revenue
646.1M
↓ 2.18%
Net Income
-81.9M
↑ 183.45%
Net Profit Margin
-12.67%
↓ 8.3%
Q2 FY24Q/Q Change
Revenue
642.4M
↓ 0.57%
Net Income
-837.7M
↑ 922.93%
Net Profit Margin
-130.39%
↓ 117.72%
Q3 FY24Q/Q Change
Revenue
640.5M
↓ 0.3%
Net Income
-33.3M
↓ 96.03%
Net Profit Margin
-5.2%
↑ 125.19%
FY18Y/Y Change
Total Assets
1.5B
↑ 85.46%
Total Liabilities
515.8M
↑ 94.27%
FY19Y/Y Change
Total Assets
1.6B
↑ 4.84%
Total Liabilities
588.8M
↑ 14.16%
FY20Y/Y Change
Total Assets
17.8B
↑ 1007.75%
Total Liabilities
1.9B
↑ 217.84%
FY21Y/Y Change
Total Assets
17.7B
↓ 0.12%
Total Liabilities
1.7B
↓ 9.76%
FY22Y/Y Change
Total Assets
4.3B
↓ 75.5%
Total Liabilities
2.0B
↑ 20.65%
FY23Y/Y Change
Total Assets
4.4B
↑ 1.08%
Total Liabilities
2.1B
↑ 1.41%
Q2 FY23Q/Q Change
Total Assets
4.3B
↑ 0.17%
Total Liabilities
2.0B
↑ 0.17%
Q3 FY23Q/Q Change
Total Assets
4.3B
↑ 0.27%
Total Liabilities
2.0B
↑ 0.63%
Q4 FY23Q/Q Change
Total Assets
4.4B
↑ 1.49%
Total Liabilities
2.1B
↑ 1.59%
Q1 FY24Q/Q Change
Total Assets
4.3B
↓ 1.63%
Total Liabilities
2.0B
↓ 1.67%
Q2 FY24Q/Q Change
Total Assets
3.5B
↓ 18.45%
Total Liabilities
2.0B
↓ 0.51%
Q3 FY24Q/Q Change
Total Assets
3.5B
↑ 0.14%
Total Liabilities
2.0B
↓ 0.03%
FY18Y/Y Change
Operating Cash Flow
-4.9M
↓ 85.89%
Investing Cash Flow
-257.5M
↓ 42.57%
Financing Cash Flow
645.6M
↑ 35.8%
FY19Y/Y Change
Operating Cash Flow
29.9M
↓ 714.59%
Investing Cash Flow
25.0M
↓ 109.71%
Financing Cash Flow
35.1M
↓ 94.56%
FY20Y/Y Change
Operating Cash Flow
-53.5M
↓ 279.15%
Investing Cash Flow
-591.0M
↓ 2462.67%
Financing Cash Flow
859.1M
↑ 2348.1%
FY21Y/Y Change
Operating Cash Flow
194.0M
↓ 462.52%
Investing Cash Flow
-73.0M
↓ 87.65%
Financing Cash Flow
40.9M
↓ 95.23%
FY22Y/Y Change
Operating Cash Flow
189.3M
↓ 2.42%
Investing Cash Flow
-167.7M
↑ 129.84%
Financing Cash Flow
6.5M
↓ 84.13%
Q2 FY23Q/Q Change
Operating Cash Flow
101.2M
↑ 669.09%
Investing Cash Flow
-36.6M
↓ 19.84%
Financing Cash Flow
4.2M
↑ 25.5%
Q3 FY23Q/Q Change
Operating Cash Flow
105.6M
↑ 4.37%
Investing Cash Flow
-37.6M
↑ 2.95%
Financing Cash Flow
5.1M
↑ 20.44%

Teladoc Inc Technicals Summary

Sell

Neutral

Buy

Teladoc Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Teladoc Inc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Teladoc Inc
Teladoc Inc
30.94%
5.81%
-30.16%
-89.03%
-85.84%
Solventum Corp
Solventum Corp
-2.39%
19.63%
3.63%
3.63%
3.63%
Doximity, Inc.
Doximity, Inc.
17.7%
69.86%
105.7%
-20.25%
-8.02%
Veeva Systems Inc.
Veeva Systems Inc.
6.99%
11.75%
30.94%
-21.63%
42.53%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-3.81%
4.97%
16.19%
36.65%
36.65%
Healthequity Inc
Healthequity Inc
18.15%
31.03%
54.59%
80.8%
65.78%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Teladoc Inc
Teladoc Inc
NA
NA
-1.01
-1.17
-0.52
-0.03
NA
8.77
Solventum Corp
Solventum Corp
NA
NA
NA
6.26
0.17
0.08
NA
NA
Doximity, Inc.
Doximity, Inc.
55.4
55.4
2.42
0.9
0.19
0.12
NA
5.15
Veeva Systems Inc.
Veeva Systems Inc.
57.21
57.21
1.21
4.76
0.13
0.06
NA
32.04
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
22.59
22.59
2.06
4.28
0.22
0.06
0.0
18.2
Healthequity Inc
Healthequity Inc
86.88
86.88
1.13
2.19
0.05
0.03
NA
24.7
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Teladoc Inc
Teladoc Inc
Hold
$1.5B
-85.84%
NA
-37.91%
Solventum Corp
Solventum Corp
Hold
$10.8B
3.63%
NA
15.73%
Doximity, Inc.
Doximity, Inc.
Hold
$9.0B
-8.02%
55.4
33.69%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$34.7B
42.53%
57.21
23.91%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$37.7B
36.65%
22.59
8.56%
Healthequity Inc
Healthequity Inc
Buy
$9.1B
65.78%
86.88
9.61%

Teladoc Inc Institutional Holdings

  • BlackRock Inc

    12.55%
  • Vanguard Group Inc

    10.13%
  • ARK Investment Management LLC

    4.35%
  • State Street Corp

    3.38%
  • Point72 Asset Management, L.P.

    3.08%
  • Renaissance Technologies Corp

    2.85%

Company Information about Teladoc Inc

Teladoc Health Inc. founded by G. Byron Brooks and Michael Gorton is a multinational company for telemedicine and virtual healthcare in America. The company was incorporated in 2002 in Dallas, Texas, USA. Teladoc Health Inc. is headquartered in Purchase, New York, USA, and operates in more than 130 countries worldwide. The company has over 4,400 employees serving across the world. Teladoc Health primarily caters to telehealth services and devices, AI and analytics, medical opinions, and licensable platform services. It is the first and largest telemedicine company in the USA to have served 40 million members in 2021 and traded on the New York Stock Exchange as TDOC under the Russel 1000 component. Teledoc Health Inc. has acquired some of the major companies in the past few years such as BetterHelp in 2015, followed by Best Doctors and Advance Medical in 2017 and 2018, respectively. However, the company eventually dropped the lawsuit voluntarily after Texas passed a new bill allowing remote medical treatment without a physical meeting in 2017. In the financial year 2020, Teladoc Health Inc. generated annual revenue of $1.093 billion. Currently Teladoc Inc has a market cap of $1.22 Billion. It has a P.E ratio of -1.21. The shares of Teladoc Inc are trading at $12.02. .

Organization
Teladoc Inc
Employees
4816
CEO
Ms. Mala Murthy
Industry
Health Services

FAQs